The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Clinical trial NCT05540327 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05540327
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2022-09-16
Primary completion: 2028-08-12
Enrollment: 379

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.